FDA Gives Orphan Drug Designation to CAR T-cell Therapy for Mesothelioma
By: Devin Golden
October 13, 2022
A new CAR T-cell therapy for mesothelioma is getting attention from the U.S. Food and Drug Administration, which is the main governing body that approves therapies for cancers...
Read Post